<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="2019, SARS-CoV-2, a novel betacoronavirus, was identified that causes a" exact="respiratory disease" post="and pneumonia called coronavirus disease 19 (COVID-19) [ Chen"/>
 <result pre="novel betacoronavirus, was identified that causes a respiratory disease and" exact="pneumonia" post="called coronavirus disease 19 (COVID-19) [ Chen et al.,"/>
 <result pre="the betacoronaviruses human coronavirus OC43 (HCoV-OC43), human coronavirus HKU1 (HCoV-HKU1)," exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV)"/>
 <result pre="in humans and typically cause mild to moderate common cold-like" exact="respiratory disease" post="[ Channappanavar &amp;amp;; Perlman, 2017; Corman et al., 2018]."/>
 <result pre="SARS-CoV-2, result in different phenotypes. Infection experiments using the four" exact="colorectal cancer" post="cell lines Caco2, CL14, HT-29, and DLD-1 resulted in"/>
 <result pre="result in different phenotypes. Infection experiments using the four colorectal" exact="cancer" post="cell lines Caco2, CL14, HT-29, and DLD-1 resulted in"/>
 <result pre="study SARS-CoV-2 infection and replication. ;SARS-CoV-2 and SARS-CoV susceptibility of" exact="colorectal cancer" post="cell lines. A) Cytopathogenic effect (CPE) formation 48h post"/>
 <result pre="SARS-CoV-2 infection and replication. ;SARS-CoV-2 and SARS-CoV susceptibility of colorectal" exact="cancer" post="cell lines. A) Cytopathogenic effect (CPE) formation 48h post"/>
 <result pre="in new tab Figure 2. SARS-CoV-2 and SARS-CoV susceptibility of" exact="colorectal cancer" post="cell lines. A) Cytopathogenic effect (CPE) formation 48h post"/>
 <result pre="new tab Figure 2. SARS-CoV-2 and SARS-CoV susceptibility of colorectal" exact="cancer" post="cell lines. A) Cytopathogenic effect (CPE) formation 48h post"/>
 <result pre="inhibitor camostat, which is approved for the treatment of chronic" exact="pancreatitis" post="in Japan [ Ramsey et al., 2019], inhibits both"/>
 <result pre="is an alternative serine protease inhibitor, which is approved for" exact="pancreatitis" post="and [ Minakata et al., 2019; Hirota et al.,"/>
 <result pre="further serine protease inhibitor that has been previously investigated against" exact="influenza" post="viruses [ Zhirnov et al., 2011; Shen et al.,"/>
 <result pre="is used to reduce blood loss during surgery and for" exact="pancreatitis" post="[ Moggia et al., 2017; Kapadia et al., 2019]."/>
 <result pre="aerosol preparation of aprotinin is approved for the treatment of" exact="influenza" post="in Russia [ Zhirnov et al., 2011]. Since aprotinin"/>
 <result pre="cells susceptibility to SARS-CoV-2 or SARS-CoV. We found that the" exact="colorectal cancer" post="cell line CL14 supported SARS-CoV-2 replication, although it displayed"/>
 <result pre="susceptibility to SARS-CoV-2 or SARS-CoV. We found that the colorectal" exact="cancer" post="cell line CL14 supported SARS-CoV-2 replication, although it displayed"/>
 <result pre="concentrations in the lungs are approved for the treatment of" exact="influenza" post="viruses in Russia [ Zhirnov et al., 2011]. Remdesivir,"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet. 2020 Feb"/>
 <result pre="Doerr HW . Infection of cultured intestinal epithelial cells with" exact="severe acute respiratory syndrome" post="coronavirus. Cell Mol Life Sci. 2004 Aug; 61( 16):"/>
 <result pre="bronchial epithelial cells with serine and cysteine protease inhibitors prevents" exact="severe acute respiratory syndrome" post="coronavirus entry. J Virol. 2012 Jun; 86( 12): 6537–"/>
 <result pre=", Takeda M , Taguchi F. Efficient activation of the" exact="severe acute respiratory syndrome" post="coronavirus spike protein by the transmembrane protease TMPRSS2. J"/>
 <result pre=", Davidson BR , Gurusamy KS . Pharmacological interventions for" exact="acute pancreatitis." post="Cochrane Database Syst Rev. 2017 Apr 21; 4: CD011384."/>
 <result pre="human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted" exact="cancer" post="cells. Beilstein J Nanotechnol. 2019 Aug 14; 10: 1707–"/>
 <result pre="controlled trial on the assessment of camostat treatment in chronic" exact="pancreatitis" post="(TACTIC). Trials. 2019 Aug 14; 20( 1): 501. OpenUrl"/>
 <result pre=", Zhang W. TMPRSS2: A potential target for treatment of" exact="influenza" post="virus and coronavirus infections. Biochimie. 2017 Nov; 142: 1–"/>
 <result pre=", Zhang YZ . A new coronavirus associated with human" exact="respiratory disease" post="in China. Nature. 2020 Mar; 579( 7798): 265– 269."/>
 <result pre="Wang YY , Xiao GF , Shi ZL . A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
</results>
